awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47287952-D98AA58C-22CE-4293-8657-2C7674197C17
Q47287952-D98AA58C-22CE-4293-8657-2C7674197C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47287952-D98AA58C-22CE-4293-8657-2C7674197C17
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry.
P2860
Q47287952-D98AA58C-22CE-4293-8657-2C7674197C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47287952-D98AA58C-22CE-4293-8657-2C7674197C17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
35b67877caccb66eab11eb1d38afde64acff3e00
P2860
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer